Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)

18 Nov 2010 • by Natalie Aster

New York – Marketing planners in the pharmaceutical and diagnostic industries should have an understanding of the market impact of nosocomial infections (also known as a hospital-acquired infection or HAI), as they will be an important consideration in these markets in the near future.

The comprehensive report “Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) ” by Kalorama Information provides all the most recent and relevant information, epidemiological statistics and in-depth analysis on HAIs that companies need in order to enter this lucrative market, discussing in detail the market impact of a variety of nosocomial infections. The primary focus of the report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets.

Report Details:

Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)

Date: January 2009
Pages: 180
Price: US$ 3,500.00

Report Sample Abstract:

The report examines the key players in HAI infection diagnostics and pharmaceutical treatments, their revenues, and activity in the market. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology. This presages opportunities for new competitors.

The analysis presented in the report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.

More information is available in the report “Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) ” by Kalorama Information .

To order the report or ask for free sample pages contact ps@marketpublishers.com

Contacts

MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
www.marketpublishers.com